Digital Diagnostics and Intervention Services for Parkinson's Disease

Sponsor
University of Exeter
Study ID
NCT06534177
Status
Not Yet Recruiting

Notify me when recruiting opens

Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.

Not yet recruiting

Add your contact details and location so we can keep your interest tied to this study.

Conditions

  • Arthritis
  • Autoimmune Diseases
  • Basal Ganglia Diseases
  • Bone Diseases
  • Bone Diseases, Metabolic
  • Brain Diseases
  • Central Nervous System Diseases
  • Demyelinating Disease
  • Demyelinating Disease, Autoimmune, CNS
  • Immune System Diseases
  • Joint Diseases
  • Movement Disorders
  • Multiple Sclerosis
  • Musculoskeletal Diseases
  • Nervous System Diseases
  • Neuro-Degenerative Disease
  • Osteoporosis
  • Parkinson Disease
  • Synucleinopathies

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Accepted

Study Details

People with Parkinson's have infrequent clinical consultation (once every 12-18 months) and limited rehabilitation. Assessment play an important role in these consultations to help clinicians understand patients' health status and disease progression necessary to adjust treatment plans. The current way of measuring is the UPDRS which needs a clinician to do this and takes 30 minutes. There is a strong need for more frequent and accurate Parkinson's assessments in the clinic and at home to detect changes early and then give appropriate support and drug and physiotherapy quickly. There is a need to develop good home digital physiotherapy tools to increase the amount of therapy. Here the investigators are testing new digital technologies to do these assessments in the home and clinic and a new digital physiotherapy device in the home. The investigators aim to conduct a clinical study with 50 people with Parkinson's (50 from UK) with the UPDRS, (a rating scale that is commonly used in clinical settings to evaluate the progression of Parkinson's disease) and 30 healthy adults. The investigators will develop and investigate if two new digital devices, one the MachineMD that measures eye movement and one the gaitQ that measures gait can be used instead of the MDS-UPDRS (motor) using digital gait and ophthalmic features in the clinic setting. The investigators will investigate the effect of a physiotherapy gait intervention gaitQ Tempo in the home context for two weeks and of doing the gait measure at home. The investigators will determine the potential of the gaitQ intervention to improve key gait metrics in order to collect clinical evidence and of using the gaitQ as a cuing system over a 2-week period on gait and other movement measures in the home and community

Key Dates

First listed
Aug 2, 2024
Start date
Oct 15, 2024
Status verified
Aug 2024
Primary completion
Jul 31, 2025
Completion
Mar 1, 2026

Study Design

Enrollment
80 participants (estimated)

Arms

  • Arm: Participants with long-term conditions affecting movement
    A total number of 50 people with long-term conditions affecting their movement include people with Parkinson's
  • Arm: Healthy control
    A total number of 30 healthy people with no condition impacting their movement and walking ability.

Primary Outcome Measure

Lab validation of MachineMD opthalamic device vs UPDRS [ Time Frame: 2 weeks ]

Find similar trials

Nationwide
Multiple sclerosis trialsParkinson's disease trialsNeurology trialsBrain disorders trialsAutoimmune disease trials

Related Studies